183 related articles for article (PubMed ID: 19111562)
41. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease.
Carter JG; Cherry J; Williams K; Turner S; Bates DO; Churchill AJ
Curr Eye Res; 2011 Apr; 36(4):328-35. PubMed ID: 21309690
[TBL] [Abstract][Full Text] [Related]
42. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
Shih SR; Krug RM
EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
[TBL] [Abstract][Full Text] [Related]
43. RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.
Sharp A; Pichert G; Lucassen A; Eccles D
Hum Mutat; 2004 Sep; 24(3):272. PubMed ID: 15300854
[TBL] [Abstract][Full Text] [Related]
44. Exon 10 skipping in ACAT1 caused by a novel c.949G>A mutation located at an exonic splice enhancer site.
Otsuka H; Sasai H; Nakama M; Aoyama Y; Abdelkreem E; Ohnishi H; Konstantopoulou V; Sass JO; Fukao T
Mol Med Rep; 2016 Nov; 14(5):4906-4910. PubMed ID: 27748876
[TBL] [Abstract][Full Text] [Related]
45. Identification of a splicing enhancer in MLH1 using COMPARE, a new assay for determination of relative RNA splicing efficiencies.
Xu DQ; Mattox W
Hum Mol Genet; 2006 Jan; 15(2):329-36. PubMed ID: 16357104
[TBL] [Abstract][Full Text] [Related]
46. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
47. Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions.
Karabachev AD; Martini DJ; Hermel DJ; Solcz D; Richardson ME; Pesaran T; Sarkar IN; Greenblatt MS
PLoS One; 2020; 15(8):e0233673. PubMed ID: 32750050
[TBL] [Abstract][Full Text] [Related]
48. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
D'Souza I; Schellenberg GD
J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
[TBL] [Abstract][Full Text] [Related]
49. SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing.
Sen S; Talukdar I; Webster NJ
Mol Cell Biol; 2009 Feb; 29(3):871-80. PubMed ID: 19047369
[TBL] [Abstract][Full Text] [Related]
50. A silent mutation in exon 14 of the APC gene is associated with exon skipping in a FAP family.
Montera M; Piaggio F; Marchese C; Gismondi V; Stella A; Resta N; Varesco L; Guanti G; Mareni C
J Med Genet; 2001 Dec; 38(12):863-7. PubMed ID: 11768390
[No Abstract] [Full Text] [Related]
51. The c.1275A>G putative chronic pancreatitis-associated synonymous polymorphism in the glycoprotein 2 (GP2) gene decreases exon 9 inclusion.
Boulling A; Le Gac G; Dujardin G; Chen JM; Férec C
Mol Genet Metab; 2010 Mar; 99(3):319-24. PubMed ID: 19919903
[TBL] [Abstract][Full Text] [Related]
52. An erythroid differentiation-specific splicing switch in protein 4.1R mediated by the interaction of SF2/ASF with an exonic splicing enhancer.
Yang G; Huang SC; Wu JY; Benz EJ
Blood; 2005 Mar; 105(5):2146-53. PubMed ID: 15522963
[TBL] [Abstract][Full Text] [Related]
53. Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene.
Ghigna C; Giordano S; Shen H; Benvenuto F; Castiglioni F; Comoglio PM; Green MR; Riva S; Biamonti G
Mol Cell; 2005 Dec; 20(6):881-90. PubMed ID: 16364913
[TBL] [Abstract][Full Text] [Related]
54. SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy.
Wu JY; Kar A; Kuo D; Yu B; Havlioglu N
Mol Cell Biol; 2006 Sep; 26(18):6739-47. PubMed ID: 16943417
[TBL] [Abstract][Full Text] [Related]
55. Enhancer-dependent splicing of FGFR1 alpha-exon is repressed by RNA interference-mediated down-regulation of SRp55.
Jin W; Cote GJ
Cancer Res; 2004 Dec; 64(24):8901-5. PubMed ID: 15604250
[TBL] [Abstract][Full Text] [Related]
56. SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells.
Tardos JG; Eisenreich A; Deikus G; Bechhofer DH; Chandradas S; Zafar U; Rauch U; Bogdanov VY
J Thromb Haemost; 2008 May; 6(5):877-84. PubMed ID: 18315555
[TBL] [Abstract][Full Text] [Related]
57. Constitutional high expression of an APC mRNA isoform in a subset of attenuated familial adenomatous polyposis patients.
Venesio T; Balsamo A; Sfiligoi C; Fuso L; Molatore S; Ranzani GN; Risio M
J Mol Med (Berl); 2007 Mar; 85(3):305-12. PubMed ID: 17143620
[TBL] [Abstract][Full Text] [Related]
58. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer.
Sun Q; Mayeda A; Hampson RK; Krainer AR; Rottman FM
Genes Dev; 1993 Dec; 7(12B):2598-608. PubMed ID: 8276242
[TBL] [Abstract][Full Text] [Related]
59. The phenylalanine hydroxylase c.30C>G synonymous variation (p.G10G) creates a common exonic splicing silencer.
Dobrowolski SF; Andersen HS; Doktor TK; Andresen BS
Mol Genet Metab; 2010 Aug; 100(4):316-23. PubMed ID: 20457534
[TBL] [Abstract][Full Text] [Related]
60. Presumed missense and synonymous mutations in ATP7B gene cause exon skipping in Wilson disease.
Wang C; Zhou W; Huang Y; Yin H; Jin Y; Jia Z; Zhang A; Liu Z; Zheng B
Liver Int; 2018 Aug; 38(8):1504-1513. PubMed ID: 29637721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
